Tevogen Bio hosting panel at J.P. Morgan Healthcare Conference focusing on AI in biopharma.

From GlobeNewswire: 2024-12-26 12:21:56

Tevogen Bio Holdings Inc. will host panel discussions at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2025. The event will focus on AI in biopharma and pioneering the economics of health, featuring industry leaders from Microsoft, Rubix Health, and more. Tevogen is a clinical-stage specialty immunotherapy company developing precision T cell therapies for infectious diseases, cancers, and neurological disorders. The company’s leadership emphasizes patient accessibility through advanced science and innovative business models, with a focus on personalized therapeutics and disruptive business models to sustain medical innovation.



Read more at GlobeNewswire: Tevogen Bio to Host Panel Discussions “AI In Biopharma: